Marc S. Ayers
Chief Executive Officer at Romark, L.C.
Profile
Marc S.
Ayers founded Romark, L.C.
in 1994, where he is working as President & Chief Executive Officer from 1994.
Mr. Ayers also currently works at Romark Global Pharma LLC, as Director and Romark SCS, as Director.
Mr. Ayers received his graduate degree in 1981 from The University of Alabama.
Marc S. Ayers active positions
| Companies | Position | Start |
|---|---|---|
Romark, L.C.
 Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Chief Executive Officer | 1993-12-31 |
Romark Global Pharma LLC
 Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Director/Board Member | - |
Romark SCS
 Romark SCS Pharmaceuticals: MajorHealth Technology Romark SCS operates as pharmaceutical company. The company is headquartered in Luxembourg. | Director/Board Member | - |
Training of Marc S. Ayers
| The University of Alabama | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Health Technology |
Romark Global Pharma LLC
Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Health Technology |
Romark SCS
Romark SCS Pharmaceuticals: MajorHealth Technology Romark SCS operates as pharmaceutical company. The company is headquartered in Luxembourg. | Health Technology |
- Stock Market
- Insiders
- Marc S. Ayers
